TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway

Am J Pathol. 2016 May;186(5):1151-65. doi: 10.1016/j.ajpath.2015.12.016. Epub 2016 Mar 4.

Abstract

Tumor necrosis factor (TNF)-α, a key mediator of intestinal inflammation, causes an increase in intestinal epithelial tight junction (TJ) permeability by activating myosin light chain kinase (MLCK; official name MYLK3) gene. However, the precise signaling cascades that mediate the TNF-α-induced activation of MLCK gene and increase in TJ permeability remain unclear. Our aims were to delineate the upstream signaling mechanisms that regulate the TNF-α modulation of intestinal TJ barrier function with the use of in vitro and in vivo intestinal epithelial model systems. TNF-α caused a rapid activation of both canonical and noncanonical NF-κB pathway. NF-κB-inducing kinase (NIK) and mitogen-activated protein kinase kinase-1 (MEKK-1) were activated in response to TNF-α. NIK mediated the TNF-α activation of inhibitory κB kinase (IKK)-α, and MEKK1 mediated the activation of IKK complex, including IKK-β. NIK/IKK-α axis regulated the activation of both NF-κB p50/p65 and RelB/p52 pathways. Surprisingly, the siRNA induced knockdown of NIK, but not MEKK-1, prevented the TNF-α activation of both NF-κB p50/p65 and RelB/p52 and the increase in intestinal TJ permeability. Moreover, NIK/IKK-α/NF-κB p50/p65 axis mediated the TNF-α-induced MLCK gene activation and the subsequent MLCK increase in intestinal TJ permeability. In conclusion, our data show that NIK/IKK-α/regulates the activation of NF-κB p50/p65 and plays an integral role in the TNF-α-induced activation of MLCK gene and increase in intestinal TJ permeability.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Caco-2 Cells
  • Cells, Cultured
  • Humans
  • I-kappa B Kinase / metabolism*
  • Intestine, Small / physiology
  • MAP Kinase Kinase Kinase 1 / metabolism*
  • MAP Kinase Signaling System / physiology
  • Mice
  • Myosin-Light-Chain Kinase / genetics
  • Myosin-Light-Chain Kinase / physiology
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism*
  • NF-kappa B p50 Subunit / metabolism
  • NF-kappa B p52 Subunit / metabolism
  • Permeability
  • Promoter Regions, Genetic / physiology
  • RNA, Small Interfering / metabolism
  • Tight Junctions / physiology*
  • Transcription Factor RelA / metabolism
  • Transfection
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • NF-kappa B
  • NF-kappa B p50 Subunit
  • NF-kappa B p52 Subunit
  • RNA, Small Interfering
  • Rela protein, mouse
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • I-kappa B Kinase
  • Myosin-Light-Chain Kinase
  • cardiac myosin light chain kinase, human
  • MAP Kinase Kinase Kinase 1
  • MAP3K1 protein, human